• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌诱导化疗反应的临床和组织学预测因素

Clinical and Histologic Predictive Factors of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma.

作者信息

Karpathiou Georgia, Giroult Jean-Baptiste, Forest Fabien, Fournel Pierre, Monaya Alessandra, Froudarakis Marios, Dumollard Jean Marc, Prades Jean Michel, Gavid Marie, Peoc'h Michel

机构信息

From the Department of Pathology.

Department of Head and Neck Surgery.

出版信息

Am J Clin Pathol. 2016 Nov 1;146(5):546-553. doi: 10.1093/ajcp/aqw145.

DOI:10.1093/ajcp/aqw145
PMID:27694130
Abstract

OBJECTIVES

Induction chemotherapy (IC) is occasionally used in head and neck cancer, leading to less extensive surgery and reduced need for irradiation. Factors predicting the response to IC have not been determined. In this study, we investigated the clinical and histopathologic factors that predict the response to IC.

METHODS

Head and neck squamous cell carcinomas from 81 patients were analyzed; clinical factors, histologic parameters, and expression of p16 and p53 were correlated with response to chemotherapy and prognosis.

RESULTS

Factors predicting a good response to IC were the nonoropharyngeal localization, a rich lymphocytic tissue response, and a low platelet-to-lymphocyte blood ratio before treatment. Response to IC did not correlate with prognosis, whereas a low neutrophil-to-lymphocyte ratio (NLR), the absence of a desmoplastic reaction, a rich lymphocytic tissue response, and the overexpression of p53 were associated with better prognosis.

CONCLUSIONS

Lymphocytic tissue response, NLR, and nonoropharyngeal localization are factors predictive of response to IC.

摘要

目的

诱导化疗(IC)偶尔用于头颈癌,可减少手术范围并降低放疗需求。预测IC反应的因素尚未确定。在本研究中,我们调查了预测IC反应的临床和组织病理学因素。

方法

分析了81例患者的头颈鳞状细胞癌;临床因素、组织学参数以及p16和p53的表达与化疗反应和预后相关。

结果

预测IC良好反应的因素为非口咽定位、丰富的淋巴细胞组织反应以及治疗前低血小板与淋巴细胞血比。IC反应与预后无关,而低中性粒细胞与淋巴细胞比(NLR)、无促结缔组织增生性反应、丰富的淋巴细胞组织反应以及p53过表达与较好预后相关。

结论

淋巴细胞组织反应、NLR和非口咽定位是预测IC反应的因素。

相似文献

1
Clinical and Histologic Predictive Factors of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌诱导化疗反应的临床和组织学预测因素
Am J Clin Pathol. 2016 Nov 1;146(5):546-553. doi: 10.1093/ajcp/aqw145.
2
Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.鼻窦和鼻腔头颈部鳞状细胞癌的诱导化疗:在器官保留中的作用
Korean J Intern Med. 2016 May;31(3):570-8. doi: 10.3904/kjim.2015.020. Epub 2016 Mar 15.
3
Correlation of Ki-67 Proliferative Antigen Expression and Tumor Response to Induction Chemotherapy Containing Cell Cycle-Specific Agents in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌中Ki-67增殖抗原表达与肿瘤对含细胞周期特异性药物诱导化疗反应的相关性
Head Neck Pathol. 2017 Sep;11(3):338-345. doi: 10.1007/s12105-016-0775-9. Epub 2016 Dec 26.
4
beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial.β-微管蛋白 II 表达强烈预测接受诱导化疗的局部晚期头颈部鳞状细胞癌患者的结局:TAX 324 试验的伴随分析。
J Clin Oncol. 2009 Dec 20;27(36):6222-8. doi: 10.1200/JCO.2009.23.0953. Epub 2009 Nov 16.
5
Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.槟榔咀嚼史是接受多西他赛、顺铂和氟尿嘧啶诱导化疗的局部晚期IV期头颈部鳞状细胞癌吸烟患者的独立预后指标。
World J Surg Oncol. 2016 Mar 22;14:86. doi: 10.1186/s12957-016-0844-2.
6
Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.头颈部鳞状细胞癌:b值为1000和2000 s/mm²的扩散加权磁共振成像用于预测诱导化疗反应的比较
Magn Reson Med Sci. 2015;14(4):337-45. doi: 10.2463/mrms.2015-0003. Epub 2015 Jun 23.
7
Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma.III类β微管蛋白而非ERCC1,是局部晚期头颈部鳞状细胞癌的一种强有力的预测和预后标志物。
Ann Oncol. 2009 Aug;20(8):1414-9. doi: 10.1093/annonc/mdp002. Epub 2009 May 25.
8
Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.肿瘤分期、淋巴结分期、p53基因状态及bcl-2蛋白表达作为头颈部鳞状细胞癌患者对铂类-氟尿嘧啶化疗肿瘤反应的预测指标。
Br J Cancer. 2002 Dec 2;87(12):1390-5. doi: 10.1038/sj.bjc.6600648.
9
A phase I study of cabazitaxel in combination with platinum and 5-fluorouracil (PF) in locally advanced squamous cell carcinoma of head and neck (LA-SCCHN).卡巴他赛联合铂类和氟尿嘧啶(PF)治疗局部晚期头颈部鳞状细胞癌(LA-SCCHN)的 I 期研究。
Oral Oncol. 2017 Aug;71:99-104. doi: 10.1016/j.oraloncology.2017.05.008. Epub 2017 Jun 16.
10
Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.晚期头颈部鳞状细胞癌诱导化疗后同步放化疗:多西他赛、顺铂和5-氟尿嘧啶II期研究的四年随访最终结果
Oral Oncol. 2006 Aug;42(7):675-84. doi: 10.1016/j.oraloncology.2005.12.006. Epub 2006 May 30.

引用本文的文献

1
Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies.脊索瘤中髓系、T细胞和自然杀伤细胞肿瘤免疫微环境的多光谱免疫荧光评估可指导免疫治疗策略。
Front Oncol. 2022 Oct 21;12:1012058. doi: 10.3389/fonc.2022.1012058. eCollection 2022.
2
Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers.头颈部癌诱导化疗反应和毒性的预测生物标志物
Front Oncol. 2022 Jul 6;12:900903. doi: 10.3389/fonc.2022.900903. eCollection 2022.
3
Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study.
不同的炎症血液标志物与 HPV 阴性头颈部鳞状细胞癌的特定结局相关:一项回顾性队列研究。
BMC Cancer. 2022 Mar 5;22(1):243. doi: 10.1186/s12885-022-09327-4.
4
Laryngeal Tumor Microenvironment.喉肿瘤微环境。
Adv Exp Med Biol. 2020;1296:79-101. doi: 10.1007/978-3-030-59038-3_5.
5
Immune Cell Infiltrates and Neutrophil-to-Lymphocyte Ratio in Relation to Response to Chemotherapy and Prognosis in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.喉癌和下咽鳞状细胞癌中免疫细胞浸润及中性粒细胞与淋巴细胞比值与化疗反应和预后的关系
Cancers (Basel). 2021 Apr 25;13(9):2079. doi: 10.3390/cancers13092079.
6
Chemotherapy-induced changes in bronchoalveolar lavage fluid CD4 + and CD8 + cells of the opposite lung to the cancer.化疗引起的与癌症相对应的肺支气管肺泡灌洗液中 CD4+和 CD8+细胞的变化。
Sci Rep. 2020 Nov 16;10(1):19927. doi: 10.1038/s41598-020-76752-5.
7
Gene Expression Comparison Between the Primary Tumor and its Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: A Pilot Study.头颈部鳞状细胞癌原发灶与淋巴结转移灶的基因表达比较:一项初步研究。
Cancer Genomics Proteomics. 2019 May-Jun;16(3):155-161. doi: 10.21873/cgp.20121.
8
Stromal versus tumoral inflammation differentially contribute to metastasis and poor survival in laryngeal squamous cell carcinoma.基质炎症与肿瘤炎症对喉鳞状细胞癌的转移和不良生存有不同的影响。
Oncotarget. 2018 Jan 3;9(9):8415-8426. doi: 10.18632/oncotarget.23865. eCollection 2018 Feb 2.
9
Association between PD-L1 expression combined with tumor-infiltrating lymphocytes and the prognosis of patients with advanced hypopharyngeal squamous cell carcinoma.程序性死亡配体1(PD-L1)表达联合肿瘤浸润淋巴细胞与晚期下咽鳞状细胞癌患者预后的相关性
Oncotarget. 2017 Oct 6;8(54):92699-92714. doi: 10.18632/oncotarget.21564. eCollection 2017 Nov 3.
10
Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.免疫微环境在喉咽鳞状细胞癌中的预后影响:免疫细胞亚型、免疫抑制途径及临床病理特征
Oncotarget. 2017 Mar 21;8(12):19310-19322. doi: 10.18632/oncotarget.14242.